ST. LOUIS, Sept. 24 /PRNewswire-FirstCall/ — Stereotaxis, Inc.
(Nasdaq:
STXS) today announced that executive management will present at
The Fifth Annual JMP Securities Healthcare Conference on Tuesday,
September 28, 2010 at 8:30 a.m. ET in New York. Dan Johnston, Chief
Financial Officer, will provide an overview of the Company’s
business strategy and recent corporate developments.
Attendance at this conference is by invitation only. A live
audio and slides webcast of Stereotaxis’ presentation may be
accessed through the Company’s website at http://www.stereotaxis.com/Investor-Relations.
The replay will be available for 90 days.
About Stereotaxis
Stereotaxis designs, manufactures and markets an advanced
cardiology instrument control system for use in a hospital’s
interventional surgical suite to enhance the treatment of
arrhythmias and coronary artery disease. The Stereotaxis system is
designed to enable physicians to complete more complex
interventional procedures by providing image guided delivery of
catheters and guidewires through the blood vessels and chambers of
the heart to treatment sites. This is achieved using
computer-controlled, externally applied magnetic fields that govern
the motion of the working tip of the catheter or guidewire,
resulting in improved navigation, shorter procedure time and
reduced x-ray exposure. The unparalleled clinical capability of
Stereotaxis has driven more than 130 hospitals to adopt magnetic
navigation for a growing number of complex ablation cases in all
four chambers of the heart. Stereotaxis technology is now installed
and used by 9 out of the Top 10 Best U.S. Heart Hospitals as ranked
by U.S. News and World Report, and more than one third of the EP
academic training centers in the United States have included
Stereotaxis into their arrhythmia treatmen
‘/>”/>
